SBC Medical Group Expands into Thailand Through Partnership with BLEZ ASIA

SBC Medical Group Holdings Inc., Japan's leading aesthetic medical clinic operator, has entered an e-consulting agreement with BLEZ ASIA Co., Ltd. to expand into Thailand, focusing on establishing a dermatological clinic in Bangkok's Asok district by year-end. This marks SBC's second international expansion after entering Singapore in 2024, targeting a Thai aesthetic medicine market projected to reach nearly $1.2 billion by 2033 with a 13.5% compound annual growth rate. The fragmented local market of small-scale operators providing inconsistent service, combined with approximately 60,000 Japanese expatriates seeking Japanese-quality treatments, creates ideal conditions for SBC's entry.

Under the agreement, SBC will provide management support to the new clinic, advising on clinical protocols aligned with its quality standards and assisting in selecting medical devices and treatment methods optimized for local skin characteristics and environmental conditions. The clinic will primarily focus on dermatological treatments such as pigmentation and spot removal. BLEZ ASIA, which operates more than twenty pharmacies and clinics in Thailand and is trusted by Japanese expatriates and local patients, brings essential local market knowledge and reputation to the partnership. This collaboration represents a key component of SBC's broader Asia expansion strategy and accelerates regional growth following its Singapore launch through partnership with Aesthetic Healthcare Holdings.

Yoshiyuki Aikawa, CEO of SBC, emphasized the strategic importance, stating that Japanese aesthetic medicine is globally competitive for its precision and high safety standards. Partnering with a trusted local leader like BLEZ in the fast-growing Thai market represents a significant step forward in SBC's Asia strategy. The company aims to create a model where Japan's advanced medical services can take root locally and deliver new value, beginning with the Japanese expatriate community before expanding to serve the broader Thai market. This expansion comes as SBC reports strong domestic performance, with annual patient visits growing 15% year-over-year in the third quarter and a 72% return customer rate, alongside a recent pricing structure overhaul to attract and retain customers in Japan.

Naoki Iida, CEO of BLEZ ASIA, noted that the Thai aesthetic medicine market continues to grow rapidly with increasing focus on quality and safety, making the partnership with SBC an invaluable opportunity to establish Japanese-standard, high-quality medical services in Thailand. Both companies aim to address customer demand for high-quality, affordable aesthetic treatments that offer subtle, natural-looking enhancements with minimal downtime. The collaboration seeks to build a brand trusted and loved by the community for years to come, combining SBC's medical expertise with BLEZ ASIA's local market knowledge. This expansion represents SBC's continued commitment to providing consistently high-level medical services while establishing new value in international aesthetic medicine markets, as detailed in their corporate strategy at https://www.sbcmedicalgroup.com.